First To Know Pregnancy Test - Clinical Evaluation Protocol
NCT: NCT07304531 · COMPLETED
Brief Summary
This study is evaluating the ADEXUSDx® hCG CLIA moderately complex, FDA-cleared test for potential over the counter (OTC) use and marketing as the First To Know® (FTK) Pregnancy test. The investigational FTK Pregnancy test will be used to assess its clinical performance in the intended use population (i.e., lay users) through self-testing in a simulated home setting.
Frequently Asked Questions
What is First To Know Pregnancy Test - Clinical Evaluation Protocol?
First To Know Pregnancy Test - Clinical Evaluation Protocol is a clinical trial registered under NCT07304531. Current status: COMPLETED.
What is the status of NCT07304531?
The current status of NCT07304531 (First To Know Pregnancy Test - Clinical Evaluation Protocol) is: COMPLETED.
When did First To Know Pregnancy Test - Clinical Evaluation Protocol start?
First To Know Pregnancy Test - Clinical Evaluation Protocol started on 2025-10-14.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.